Wu H - Search Results

1

Total Chemical Synthesis of Palmitoyl-Conjugated Insulin.

Liu M, Li Q, Delaine C, Wu H, Arsenakis Y, White BF, Forbes BE, Chandrashekar C, Hossain MA. Liu M, et al. Among authors: wu h. ACS Omega. 2023 Apr 6;8(15):13715-13720. doi: 10.1021/acsomega.2c07918. eCollection 2023 Apr 18. ACS Omega. 2023. PMID: 37091377 Free PMC article.

2

Engineering of a Biologically Active Insulin Dimer.

Liu M, White BF, Praveen P, Li W, Lin F, Wu H, Li R, Delaine C, Forbes BE, Wade JD, Hossain MA. Liu M, et al. Among authors: wu h. J Med Chem. 2021 Dec 9;64(23):17448-17454. doi: 10.1021/acs.jmedchem.1c01594. Epub 2021 Nov 19. J Med Chem. 2021. PMID: 34797669

3

A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity.

Praveen P, Wang C, Handley TNG, Wu H, Samuel CS, Bathgate RAD, Hossain MA. Praveen P, et al. Among authors: wu h. Int J Mol Sci. 2023 Apr 1;24(7):6616. doi: 10.3390/ijms24076616. Int J Mol Sci. 2023. PMID: 37047588 Free PMC article.

4

Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.

Hossain MA, Praveen P, Noorzi NA, Wu H, Harrison IP, Handley T, Selemidis S, Samuel CS, Bathgate RAD. Hossain MA, et al. Among authors: wu h. ACS Pharmacol Transl Sci. 2023 May 3;6(5):842-853. doi: 10.1021/acsptsci.3c00053. eCollection 2023 May 12. ACS Pharmacol Transl Sci. 2023. PMID: 37200817 Free PMC article.

5

Further Developments towards a Minimal Potent Derivative of Human Relaxin-2.

Handley TNG, Praveen P, Tailhades J, Wu H, Bathgate RAD, Hossain MA. Handley TNG, et al. Among authors: wu h. Int J Mol Sci. 2023 Aug 11;24(16):12670. doi: 10.3390/ijms241612670. Int J Mol Sci. 2023. PMID: 37628851 Free PMC article.

6

Total Chemical Synthesis of Aggregation-Prone Disulfide-Rich Starfish Peptides.

Wu H, Praveen P, Handley TNG, Chandrashekar C, Cummins SF, Bathgate RAD, Hossain MA. Wu H, et al. Chemistry. 2024 Apr 12:e202400933. doi: 10.1002/chem.202400933. Online ahead of print. Chemistry. 2024. PMID: 38609334

7

Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4.

Wu H, Handley TNG, Hoare BL, Hartono HA, Scott DJ, Chalmers DK, Bathgate RAD, Hossain MA. Wu H, et al. Biochem Pharmacol. 2024 Jun;224:116239. doi: 10.1016/j.bcp.2024.116239. Epub 2024 Apr 27. Biochem Pharmacol. 2024. PMID: 38679208

8

Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.

Wu H, Hoare BL, Handley TNG, Akhter Hossain M, Bathgate RAD. Wu H, et al. Biochem Pharmacol. 2024 Jun;224:116238. doi: 10.1016/j.bcp.2024.116238. Epub 2024 Apr 26. Biochem Pharmacol. 2024. PMID: 38677442

9

Optimizing cardiopulmonary rehabilitation duration for long COVID patients: an exercise physiology monitoring approach.

Szarvas Z, Fekete M, Szollosi GJ, Kup K, Horvath R, Shimizu M, Tsuhiya F, Choi HE, Wu HT, Fazekas-Pongor V, Pete KN, Cserjesi R, Bakos R, Gobel O, Gyongyosi K, Pinter R, Kolozsvari D, Kovats Z, Yabluchanskiy A, Owens CD, Ungvari Z, Tarantini S, Horvath G, Muller V, Varga JT. Szarvas Z, et al. Among authors: wu ht. Geroscience. 2024 May 21. doi: 10.1007/s11357-024-01179-z. Online ahead of print. Geroscience. 2024. PMID: 38771423

10

A large-scale, multicenter characterization of BRAF G469V/A-mutant non-small cell lung cancer.

Wu H, Feng J, Lu S, Huang J. Wu H, et al. Cancer Med. 2024 May;13(10):e7305. doi: 10.1002/cam4.7305. Cancer Med. 2024. PMID: 38770647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43,965 results

Search Page